Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.

about

Pharmacogenomic discovery using cell-based models Use of cell lines in the investigation of pharmacogenetic loci.Modulatory Effect of Betulinic Acid on the Genotoxicity Induced by Different Mutagens in V79 Cells.Etoposide pathway.

P2860

Q28392982-D974BEC4-4C9E-48A4-A3D4-2A3535B445A3 Q37436398-99E40FE0-5697-47E5-965A-5525A3079A7E Q40903088-5489C0B1-611D-4EB3-9924-D7E64755663C Q42878172-FD5192A6-33F5-4C4B-99E6-75FDFD88AAF5

P2860

Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q36973276

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Etoposide sensitivity does not ...... elated acute myeloid leukemia.

@en

type

Item

label

Etoposide sensitivity does not ...... elated acute myeloid leukemia.

@en

prefLabel

Etoposide sensitivity does not ...... elated acute myeloid leukemia.

@en

P1476

Etoposide sensitivity does not ...... elated acute myeloid leukemia.

@en

P2093

A Bogni

http://www.w3.org/2001/XMLSchema#string

C Cheng

http://www.w3.org/2001/XMLSchema#string

C-H Pui

http://www.w3.org/2001/XMLSchema#string

D Pei

http://www.w3.org/2001/XMLSchema#string

J C C Rocha

http://www.w3.org/2001/XMLSchema#string

J Yang

http://www.w3.org/2001/XMLSchema#string

M E Dolan

http://www.w3.org/2001/XMLSchema#string

M V Relling

http://www.w3.org/2001/XMLSchema#string

W K Bleibel

http://www.w3.org/2001/XMLSchema#string

W Liu

http://www.w3.org/2001/XMLSchema#string

P2860

New insight into the molecular mechanisms of MLL-associated leukemia

A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.

Topoisomerase II inhibitor-related acute myeloid leukaemia.

Radiation and the microenvironment - tumorigenesis and therapy.

In vivo stability and kinetics of absorption and disposition of 3' phosphopropyl amine oligonucleotides

Nucleotide-resolution mapping of topoisomerase-mediated and apoptotic DNA strand scissions at or near an MLL translocation hotspot

MLL-rearranged leukemias: insights from gene expression profiling.

Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies.

Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.

P304

691-697

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CLPT.2008.86

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5342327

http://www.w3.org/2001/XMLSchema#string

P698

18509329

http://www.w3.org/2001/XMLSchema#string

P921

therapy-related acute myeloid leukemia

P932

2583166

http://www.w3.org/2001/XMLSchema#string

Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.

about

P2860

P2860

Etoposide sensitivity does not predict MLL rearrangements or risk of therapy-related acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932